Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - prilocaine hydrochloride, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; sodium hydroxide; hydrochloric acid - indications as at 12 march 1996: citanest solutions are indicated for the production of local or regional anaesthesia by infiltration techniques; intravenous regional anaesthesia; by peripheral nerve block techniques such as intercostal blocks; major plexus blocks such as brachial plexus blocks and by epidural and subarachnoid blocks.

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - prilocaine hydrochloride - solution for injection - prilocaine hydrochloride 10 mg/ml - anesthetics

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - prilocaine hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride - citanest solutions are indicated for the production of local or regional anaesthesia by infiltration techniques; intravenous regional anaesthesia; by peripheral nerve block techniques such as intercostal blocks; major plexus blocks such as brachial plexus blocks and by epidural and subarachnoid blocks.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - prilocaine hydrochloride - solution for injection - 10mg/1ml

Ireland - English - HPRA (Health Products Regulatory Authority)

dentsply detrey gmbh - felypressin; prilocaine hydrochloride - solution for injection - 3 %w/v +0.54 microgram(s)/millilitre - amides; prilocaine, combinations

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - prilocaine hydrochloride, quantity: 20 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; sodium chloride; water for injections - citanest solutions are indicated for the production of local or regional anaesthesia by infiltration techniques; intravenous regional anesthesia; by peripheral nerve block techniques such as intercostal blocks; major plexus blocks such as brachial plexus blocks and by epidural and subarachnoid blocks.

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - prilocaine hydrochloride 1%; prilocaine hydrochloride 10 mg/ml - solution for injection - 1 % - active: prilocaine hydrochloride 1% excipient: sodium chloride sodium hydroxide water for injection active: prilocaine hydrochloride 10 mg/ml excipient: hydrochloric acid as 2m solution for ph adjustment (ph 5-7) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 5-7) water for injection

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - prilocaine hydrochloride - solution for injection - 10mg/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

dentsply sirona (nz) limited - felypressin 0.54 µg/ml; prilocaine hydrochloride 3% (30mg/ml.);   - solution for injection - active: felypressin 0.54 µg/ml prilocaine hydrochloride 3% (30mg/ml.)   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - infiltration anaesthesia in dentistry, where there is no need for profound ischaemia in the injected area.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading ltd. - prilocaine hydrochloride 10 mg/ml - solution for injection - 1 % - prilocaine hydrochloride 10 mg/ml - prilocaine